Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Metastatic Transitional (Urothelial) Tract Cancer 31
Oct 01, 2019: Jounce Therapeutics to present Poster on Vopratelimab at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting 31
Sep 17, 2019: Seattle Genetics announces presentation of new clinical data from enfortumab vedotin at the European Society for Medical Oncology (ESMO) 2019 Congress 31
Clinical Trial Profile Snapshots 33
Appendix 225
Abbreviations 225
Definitions 225
Research Methodology 226
Secondary Research 226
About GlobalData 227
Contact Us 227
Disclaimer 227
Source 228
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region, 2019* 8
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 16
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 19
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase, 2019* 22
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30
List of Figures
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 16
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 19
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30
GlobalData Methodology 226
【免責事項】
https://www.marketreport.jp/reports-disclaimer